The Funding Spree for Neuroscience Startups: Venture Capital, Angel Investors, and Big Pharma betting big on Neuroscience
Lloyd Price
NOVEMBER 2, 2018
In October 2018, pharmaceutical giant Pfizer and private-equity firm Bain Capital LP announced the formation of Cerevel Therapeutics LLC, a drug-discovery collaboration for central nervous system disorders. Pfizer aims to invest $150 million in biotech startups focused on neurometabolic disorders, neurodegeneration, and neuroinflammation.
Let's personalize your content